Rhode Island House Bill H6647

Rhode Island 2022 Regular Session

• Introduced: 1/6/22
• Refer: 1/6/22

Caption

Medical Insurance Coverage For Epinephrine Injectors

Impact

If passed, HB 6647 would amend several chapters of the Rhode Island General Laws related to insurance, specifically impacting health insurance plans and nonprofit health service corporations. The bill complements existing healthcare regulations by adding provisions that directly address the need for timely administration of epinephrine in cases of severe allergic reactions. This move is expected to improve health outcomes for individuals at risk and may reduce the overall burden on emergency services by ensuring that patients have the necessary tools to manage their conditions more effectively at home.

Summary

House Bill 6647, introduced in January 2022, aims to ensure that all health insurance contracts that provide prescription coverage in Rhode Island will include coverage for prescribed epinephrine injectors and cartridges without the requirement of copayments or deductibles. This legislative measure recognizes the critical nature of epinephrine injectors as life-saving devices, which are often administered in emergency situations by non-professionals. By mandating coverage for these injectors, the bill seeks to promote their accessibility and usage among individuals who may need them in urgent health crises.

Contention

While the bill has the potential to significantly benefit those at risk of anaphylactic reactions, discussions may arise concerning the financial implications for insurance providers. Some insurers might express concerns about the additional costs associated with required coverage for these injectors. However, proponents of the bill argue that this is a justified expense considering the critical need for immediate access to life-saving medication, which could save lives and reduce emergency healthcare costs in the long run.